Ligands for E3 Ligase Inhibitors

von Hippel-Lindau (VHL)

MDM2

Cereblon

IAP

Ligands for E3 Ligase Modulators

Product Name	von Hippel-Lindau (VHL)	MDM2	Cereblon	IAP	Purity
Lenalidomide			Cereblon		99.91%
Pomalidomide			Cereblon		99.96%
Eragidomide			Cereblon		99.76%
VH032	VHL				99.64%
(S,R,S)-AHPC-Me hydrochloride	VHL				99.59%
Cemsidomide			Cereblon, Kd: 0.9 nM		98.94%
Golcadomide			Cereblon
(S,R,S)-AHPC monohydrochloride	VHL				99.54%
VH032-cyclopropane-F	VHL				99.39%
(S,S,S)-AHPC hydrochloride	VHL				99.90%
Lenalidomide-Br			Cereblon		99.86%
Lenalidomide hemihydrate			Cereblon		99.67%
(S,R,S)-AHPC	VHL				99.13%
Lenalidomide-OH			Cereblon		99.48%
VL285	VHL				98.84%
(S,R,S)-AHPC-Me	VHL				98.70%
(S)-Thalidomide			Cereblon		99.65%
VHL Ligand 8	VHL				99.71%
KB02-COOH			Cereblon		99.39%
Nutlin carboxylic acid		MDM2			98.36%
(S,R,S)-AHPC-Boc	VHL
CRBN modulator-1			Cereblon		98.06%
CC-17369			Cereblon		98.13%
cIAP1 ligand 1				cIAP1	99.07%
Cereblon inhibitor 1			Cereblon		99.19%
VH 101, thiol	VHL
(S,R,S)-AHPC-Me dihydrochloride	VHL				99.54%
E3 ligase Ligand 23			Cereblon		99.71%
VH032 thiol	VHL
Lenalidomide hydrochloride			Cereblon
DA-PROTAC	VHL
E3 ligase Ligand 22			Cereblon
Pomalidomide-6-O-CH3			Cereblon
(4R,5S)-Nutlin carboxylic acid		MDM2
β-Naphthoflavone-CH2-OH				cIAP1
Thalidomide-d₄			Cereblon		98.03%
cIAP1 ligand 2				cIAP1
(S,R,S)-AHPC dihydrochloride	VHL
LCL-PEG3-N3				IAP
Pomalidomide-6-OH			Cereblon		98.09%
N-Boc-SBP-0636457-OH				cIAP1
β-Naphthoflavone-CH2-Br				cIAP1
Pomalidomide-5-OH			Cereblon
VH 032 amide-alkylC6-acid	VHL
LCL-PEG3-N3 hydrochloride				IAP
E3 ligase Ligand 21			Cereblon
Pomalidomide-5-O-CH3			Cereblon
(R)-Thalidomide			Cereblon
(S,R,S)-AHPC TFA	VHL
Bestatin-amido-Me				cIAP1
MV-1-NH-Me				cIAP1

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。沪(浦)应急管危经许[2021]201709(QFYS)	站点地图隐私声明
Copyright © 2013-2024 MedChemExpress. All Rights Reserved.	沪ICP备15051369号-4

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。沪(浦)应急管危经许[2021]201709(QFYS)

姓名
邮箱 *

Sorry, but the email address you supplied was invalid.